Managing Myeloma
- 2014-08-10 - FDA Approves Bortezomib Retreatment in Patients with Multiple Myeloma- Market Watch The Wall Street Journal/Business Wire Press Release
- 2014-08-07 - The Tao of Myeloma -Blood
- 2014-08-04 - Breaking News: Amgen/Onyx Pharmaceutical's Carfilzomib Hits its Mark in the ASPIRE Trial in Relapsed/Refractory Patients (KRD Vs RD) - Reuters
- 2014-08-04 - Identifying Professional Education Gaps and Barriers in Multiple Myeloma Patient Care: Findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee. Clin Lymphoma Myeloma Leuk - PubMed
- 2014-07-21 - Genmab A/S - Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma
- 2014-07-14 - New Staging System Viable for Myeloma Treated With Novel Therapies - Cancer Network
- 2014-05-15 - NEWS FLASH Mayo Clinic Phase I study: Massive dose of measles vaccine clears woman's Multiple Myeloma
- 2014-05-02 - New Combination Therapy Developed for Multiple Myeloma in Preclinical Study: Potential to Overcome Resistance- Science Codex
- 2014-05-01 - Managing Myeloma is at the Oncology Nursing Society Meeting at Anaheim, CA!
- 2014-03-05 - Genmab Announces Phase III Study of Daratumumab in Relapsed or Refractory Multiple Myeloma -- NASDAQ OMX Global Newswire
- 2014-02-12 - Tom Brokaw's Multiple Myeloma Called Incurable but Treatable
- 2014-01-19 - Multiple Myeloma Research Foundation (MMRF) Research Collaboration Advances Most Comprehensive Characterization of Myeloma Genome to Date in Esteemed Scientific Journal - Press Release
- 2013-11-18 - Increased Circulating Plasma Cells On Multiparametric Flow Cytometry As An Independent Prognostic Biomarker In Newly Diagnosed Multiple Myeloma: Implications For Redefining High-Risk Myeloma - ASH Annual Meeting Abstract 2013 #1842
- 2013-09-12 - News Flash! National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Oncology -- Multiple Myeloma Have Been Updated. New Version 1.2014 (release date 9/6/2013) - Managing Myeloma Medical Director's Alert
- 2013-09-10 - Genmab Announces New Study of Daratumumab in Double Refractory Multiple Myeloma -- The Wall Street Journal